Geographic-related staging of gastric cancer
| Parameter | Total (n=333) | A. Romania (n=234) | B. Poland (n=73) | C. Hungary (n=26) | p Value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Tumor depth | A vs B vs C <0.0001 A vs B <0.0001 A vs C <0.0001 B vs C <0.0001 | ||||||||
| pT1 | 32 | 9.61% | 13 | 5.56% | 13 | 17.81% | 6 | 23.08% | |
| pT2 | 24 | 7.21% | 18 | 7.69% | 4 | 5.48% | 2 | 7.69% | |
| pT3 | 91 | 27.33% | 73 | 31.20% | 7 | 9.59% | 11 | 42.31% | |
| pT4 | 186 | 55.85% | 130 | 55.55% | 49 | 67.12% | 7 | 26.92% | |
| Lymph node status |
A vs B vs C −0.01 A vs B −0.4 A vs C −0.002 B vs C −0.04 | ||||||||
| N0 | 76 | 22.82% | 45 | 19.23% | 21 | 28.77% | 10 | 38.46% | |
| N1 | 51 | 15.32% | 37 | 15.81% | 10 | 13.70% | 4 | 15.38% | |
| N2 | 64 | 19.22% | 46 | 19.66% | 12 | 16.44% | 6 | 23.08% | |
| N3 | 142 | 42.64% | 106 | 45.30% | 30 | 41.10% | 6 | 23.08% | |
| pTN stage |
A vs B vs C <0.0001 A vs B −0.002 A vs C −0.0002 B vs C <0.0001 | ||||||||
| A1: T1N0 | 26 | 7.81% | 11 | 4.70% | 11 | 15.07% | 4 | 15.38% | |
| A2: T1N1-3 | 6 | 1.80% | 2 | 0.86% | 2 | 2.74% | 2 | 7.69% | |
| B1: T2N0 | 12 | 3.60% | 8 | 3.42% | 3 | 4.11% | 1 | 3.85% | |
| B2: T2N1-3 | 12 | 3.60% | 10 | 4.27% | 1 | 1.37% | 1 | 3.85% | |
| C1: T3N0 | 20 | 6.01% | 16 | 6.84% | 1 | 1.37% | 3 | 11.54% | |
| C2: T3N1-3 | 71 | 21.32% | 57 | 24.36% | 6 | 8.22% | 8 | 30.77% | |
| D1: T4N0 | 18 | 5.41% | 10 | 4.27% | 6 | 8.22% | 2 | 7.69% | |
| D2: T4N1-3 | 168 | 50.45% | 120 | 51.28% | 43 | 58.90% | 5 | 19.23% | |